Invesco Nasdaq Biotech UCITS ETF ISIN IE00BQ70R696, Ticker SBIO

 
Add to portfolio Watch Compare
 
 
 
 

Strategy of Invesco Nasdaq Biotech UCITS ETF

Investment strategy

The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.

 

Nasdaq Biotechnology (3)

Equity (831) United States (177) Health Care (7)
Quote
GBP 32.33
Last quote
30/10/20
24.60 52 weeks low/high 36.94
52 weeks low/high
AdDegiro
Trade ETFs for only €2.00 + 0.03% per order. Find out more
Investing can be rewarding but it is not without risk. You can lose (a part of) your deposit.
 
 

Risk and fees of Invesco Nasdaq Biotech UCITS ETF

Risk
GBP 455 m
Fund size
Fund size category

Replication

Synthetic (Unfunded swap)
Legal structure ETF
Strategy risk Long-only
Fund currency USD

Currency risk

Currency unhedged
Volatility 1 year (in GBP) 33.29% Risk category
Inception/ Listing Date 06 November 2014
Fees
0.40% p.a.
Total expense ratio
0.04% Compare 0.98%
Compare ( Equity )
Dividend/ Taxes
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Legal structure
Fund Structure Open-ended Investment Company (OEIC)
UCITS compliance Yes
Fund Provider Invesco
Administrator Northern Trust Securities Services (Ireland) Limited
Investment Advisor Assenagon Asset Management S.A.
Custodian Bank Northern Trust Fiduciary Services (Ireland) Limited
Revision Company PricewaterhouseCoopers
Fiscal Year End 30 November
Swiss representative BNP PARIBAS SECURITIES SERVICES, Paris, succursale de Zurich
Swiss paying agent BNP PARIBAS SECURITIES SERVICES, Paris, succursale de Zurich
Tax Status
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Replication, swap, securities lending
Indextype Total return index
Swap counterparty Goldman Sachs|Morgan Stanley|J.P. Morgan
Collateral manager
Securities lending No
Securities lending counterparty
 
 
 

Performance of Invesco Nasdaq Biotech UCITS ETF

Loading...
 

Description of Invesco Nasdaq Biotech UCITS ETF

The Invesco Nasdaq Biotech UCITS ETF invests in stocks with focus Health Care, United States. The dividends in the fund are reinvested (accumulating).

The total expense ratio amounts to 0.40% p.a.. The fund replicates the performance of the underlying index synthetically with a swap. The Invesco Nasdaq Biotech UCITS ETF is a large ETF with 455m GBP assets under management. The ETF is older than 5 years and is domiciled in Ireland.
 

Look for similar ETFs

 
— All quotes are 15 minutes delayed stock exchange quotes or NAVs (=daily published by fund provider). Quotes and reference data provided by Xignite, Inc., etfinfo and justETF GmbH. Returns include dividend payments. There is no warranty for completeness, accuracy and correctness for the displayed information.
Source:ETFinfo
 
 
— All quotes are 15 minutes delayed stock exchange quotes or NAVs (=daily published by fund provider). Quotes and reference data provided by Xignite, Inc., etfinfo and justETF GmbH. Returns include dividend payments. There is no warranty for completeness, accuracy and correctness for the displayed information.
Source:ETFinfo
 
 

Returns of Invesco Nasdaq Biotech UCITS ETF

Returns in years
Loading...
Returns in periods
Loading...
 
Monthly returns in a heat map
Loading...
 
— All quotes are 15 minutes delayed stock exchange quotes or NAVs (=daily published by fund provider). Quotes and reference data provided by Xignite, Inc., etfinfo and justETF GmbH. Returns include dividend payments. There is no warranty for completeness, accuracy and correctness for the displayed information.
Source:ETFinfo
 
 

Listings of Invesco Nasdaq Biotech UCITS ETF

Loading...
 
Rolling 1 year volatility

Analyse the 1 year volatility over time.

Learn more
 

Take advantage of all comfort features and portfolio comparisons with justETF Premium. The Premium version includes features like simulation of ETF portfolios, details analysis, monitoring, rebalancing and more.

Upgrade now

Track your ETF strategies online